Financials

News Discussions Technicals Forecast Seasonals

COPN fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to COSMO PHARM N operating, investing, and financing activities

COPN free cash flow for H2 24 is 55.61 M CHF. For 2024, COPN free cash flow was 150.59 M CHF and operating cash flow was 154.93 M CHF.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: CHF

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—